Gateman is a recognized and respected QA expert who brings a wealth of experience to Yale’s QA team. She joins Yale from the Dana-Farber/Harvard Cancer Center (DF/HCC), where she most recently served as director of the Quality Assurance Office for Clinical Trials (QACT). Throughout her 14-year tenure at Dana-Farber, she provided oversight of all protocol registration, data collection design of investigator-initiated clinical trials, and management of the internal auditing program. As director of the QACT, she provided leadership and management for the Data and Safety Monitoring Committee, Multi-Center Review Committee, Audit Committee, Clinical Investigations Leadership Committee, and Clinical Operations Committee (responsible for development of DF/HCC policies and procedures). She was directly involved with the Dana-Farber/Harvard Cancer Center’s participation in the NCI’s Cancer Center Support Grant as well as in a pilot initiative for the Clinical Trial Reporting Program (CTRP).
“We’re really excited to have Alyssa join our team,” said Anderson. “She has great experience having worked in quality assurance at Dana Farber that will be enormously helpful in our QA program, which spans Yale’s entire research enterprise.” Gateman is the latest hire in YCCI’s efforts to build its QA program to support clinical research at Yale. The center will continue to augment its QA staff in the months ahead to support Yale’s growing clinical research portfolio.